AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

NEOSTIGMINE METHYLSULPHATE

10 registrations across 5 African markets— 9 active

Markets with NEOSTIGMINE METHYLSULPHATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
NEOSTIGMINE METHYLSULPHATE FRESENIUS
INJECTABLE; INJECTION
🇿🇼ZimbabweFRESENIUS KABI MANUFACTURING S.A PVT LTD,activeDec 2027
NEOSTIGMINE METHYLSULPHATE FRESENIUS
INJECTABLE; INJECTION
🇿🇼ZimbabweFRESENIUS KABI MANUFACTURING S.A PVT LTD,activeDec 2027
NEOSTIGMINE METHYLSULPHATE FESENIUS 25/.L INJECTION (Each ampoule contains Neostigmine methylsulphate 2.5mg/ml)🇬🇭GhanaactiveApr 2027
NEOSTIGMINE METHYLSULPHATE FESENIUS 25/.L INJECTION (Each ampoule contains Neostigmine methylsulphate 2.5mg/ml)🇬🇭GhanaactiveApr 2027
NEOSTIGMINE_METHYLSULPHATE_2.5MG/2ML_(AMPOULES)_FRESENIUS 2.5MG/ML INJECTION
INJECTION
🇲🇼MalawiexpiredMar 2024
PHARMA-Q NEOSTIGMINE INJECTION 2,5 mg/ml (5 ml A/V)🇿🇦South AfricaPharma-Q Holdings (Pty) LtdactiveJan 1900
PHARMA-Q NEOSTIGMINE INJECTION 2,5 mg/1 ml A/A🇿🇦South AfricaPharma-Q Holdings (Pty) LtdactiveJan 1900
NEOSTIGMINE METHYLSULPHATE 2,5 mg/1 ml (AMPOULES) FRESENIUS🇿🇦South AfricaFresenius Kabi Manufacturing SA (Pty) LtdactiveJan 1900
NEOSTIGMINE METHYLSULPHATE
PARENTERAL ORDINARY AMPOULES
🇺🇬UgandaEGYPTIAN INTERNATIONAL PHARMACEUTICA L INDUSTRIES COMPANYactive
NEOSTIGMINE METHYLSULPHATE
PARENTERAL ORDINARY AMPOULES
🇺🇬UgandaEGYPTIAN INTERNATIONAL PHARMACEUTICA L INDUSTRIES COMPANYactive

NEOSTIGMINE METHYLSULPHATE in Africa — Regulatory Overview

NEOSTIGMINE METHYLSULPHATE is registered across 5 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Ghana, Uganda, Zimbabwe and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 9 (90%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.